aldosterone has been researched along with Aortic Valve Stenosis in 9 studies
Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the effects of aldosterone antagonist spironolactone on cardiac remodeling in rats with ascending aortic stenosis (AS)." | 7.83 | Effects of early aldosterone antagonism on cardiac remodeling in rats with aortic stenosis-induced pressure overload. ( Campos, DHS; Cezar, MDM; Cicogna, AC; Costa, LCO; Damatto, RL; Iyomasa, RM; Martinez, PF; Minicucci, MF; Okoshi, K; Okoshi, MP; Silva, MB, 2016) |
| " This study determined whether myocardial aldosterone and angiotensin II release occurs in patients with aortic stenosis (AS) and/or coronary heart disease (CHD) with normal left ventricular ejection fractions and no clinical heart failure." | 7.73 | Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. ( Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW, 2006) |
| "Aldosterone (Aldo) promotes proteoglycan synthesis in valve interstitial cells (VICs) from mitral valves via the mineralocorticoid receptor (MR)." | 5.72 | Sex-Related Signaling of Aldosterone/Mineralocorticoid Receptor Pathway in Calcific Aortic Stenosis. ( Álvarez de la Rosa, D; Álvarez, V; Arrieta, V; Fernández-Celis, A; Gainza, A; Garaikoetxea, M; García-Peña, A; Jaisser, F; Jover, E; López-Andrés, N; Martín-Nuñez, E; Matilla, L; Navarro, A; Sádaba, R, 2022) |
| " We evaluated the effects of aldosterone antagonist spironolactone on cardiac remodeling in rats with ascending aortic stenosis (AS)." | 3.83 | Effects of early aldosterone antagonism on cardiac remodeling in rats with aortic stenosis-induced pressure overload. ( Campos, DHS; Cezar, MDM; Cicogna, AC; Costa, LCO; Damatto, RL; Iyomasa, RM; Martinez, PF; Minicucci, MF; Okoshi, K; Okoshi, MP; Silva, MB, 2016) |
| " This study determined whether myocardial aldosterone and angiotensin II release occurs in patients with aortic stenosis (AS) and/or coronary heart disease (CHD) with normal left ventricular ejection fractions and no clinical heart failure." | 3.73 | Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease. ( Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW, 2006) |
| "Aldosterone (Aldo) promotes proteoglycan synthesis in valve interstitial cells (VICs) from mitral valves via the mineralocorticoid receptor (MR)." | 1.72 | Sex-Related Signaling of Aldosterone/Mineralocorticoid Receptor Pathway in Calcific Aortic Stenosis. ( Álvarez de la Rosa, D; Álvarez, V; Arrieta, V; Fernández-Celis, A; Gainza, A; Garaikoetxea, M; García-Peña, A; Jaisser, F; Jover, E; López-Andrés, N; Martín-Nuñez, E; Matilla, L; Navarro, A; Sádaba, R, 2022) |
| "Thirteen aortic stenosis and/or aortic regurgitation patients were matched with 13 control subjects." | 1.29 | Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease. ( Bagger, JP; Jensen, LW; Pedersen, EB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Matilla, L | 1 |
| Jover, E | 1 |
| Garaikoetxea, M | 1 |
| Martín-Nuñez, E | 1 |
| Arrieta, V | 2 |
| García-Peña, A | 2 |
| Navarro, A | 1 |
| Fernández-Celis, A | 2 |
| Gainza, A | 2 |
| Álvarez, V | 2 |
| Álvarez de la Rosa, D | 1 |
| Sádaba, R | 2 |
| Jaisser, F | 2 |
| López-Andrés, N | 2 |
| Ibarrola, J | 1 |
| Martinez-Martinez, E | 1 |
| Cachofeiro, V | 1 |
| Santamaria, E | 1 |
| Fernandez-Irigoyen, J | 1 |
| Okoshi, MP | 1 |
| Cezar, MDM | 1 |
| Iyomasa, RM | 1 |
| Silva, MB | 1 |
| Costa, LCO | 1 |
| Martinez, PF | 1 |
| Campos, DHS | 1 |
| Damatto, RL | 1 |
| Minicucci, MF | 1 |
| Cicogna, AC | 1 |
| Okoshi, K | 1 |
| Wasywich, CA | 1 |
| Webster, MW | 1 |
| Richards, AM | 1 |
| Stewart, RA | 1 |
| Szafranek, A | 1 |
| Jasinski, M | 1 |
| Kolowca, M | 1 |
| Gemel, M | 1 |
| Wos, S | 1 |
| Jensen, LW | 1 |
| Bagger, JP | 1 |
| Pedersen, EB | 1 |
| Beckerhoff, R | 1 |
| Lewin, RF | 1 |
| Raff, H | 1 |
| Findling, JW | 1 |
| Skelton, MM | 1 |
| Cowley, AW | 1 |
| King, JF | 1 |
| Dorros, G | 1 |
| Renner, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aldosterone and Aortic Valve Stenosis
| Article | Year |
|---|---|
[The effect of an angiotensin antagonist on blood pressure, renin and aldosterone secretion and its pathogenetic importance].
Topics: Aldosterone; Angiotensin II; Aortic Valve Stenosis; Bartter Syndrome; Binding, Competitive; Blood Pr | 1978 |
8 other studies available for aldosterone and Aortic Valve Stenosis
| Article | Year |
|---|---|
Sex-Related Signaling of Aldosterone/Mineralocorticoid Receptor Pathway in Calcific Aortic Stenosis.
Topics: Aldosterone; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cells, Cultured; Female; Fibrosis; Hum | 2022 |
Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12.
Topics: A Kinase Anchor Proteins; Aged; Aged, 80 and over; Aldosterone; Animals; Aortic Valve Stenosis; Case | 2018 |
Effects of early aldosterone antagonism on cardiac remodeling in rats with aortic stenosis-induced pressure overload.
Topics: Aldosterone; Animals; Aortic Valve Stenosis; Cardiomegaly; Electrocardiography; Male; Mineralocortic | 2016 |
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
Topics: Aged; Aldosterone; Angiotensin II; Aorta; Aortic Valve Stenosis; Coronary Disease; Female; Humans; M | 2006 |
Plasma ANP and renin-angiotensin-aldosterone system as new parameters describing the hemodynamics of the circulatory system after implantation of stented or stentless aortic valves.
Topics: Aged; Aldosterone; Angiotensins; Aortic Valve Stenosis; Atrial Natriuretic Factor; Biomarkers; Biopr | 2006 |
Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arginin | 1996 |
Stimulation of atrial natriuretic peptide and vasopressin during percutaneous transluminal aortic valvuloplasty.
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Aortic Valve Stenosis; Arginine Vasopressin; Atrial | 1989 |
[Diagnosis of arterial hypertension].
Topics: 17-Hydroxycorticosteroids; Aldosterone; Angiography; Aortic Valve Stenosis; Arteries; Catecholamines | 1970 |